Patent directory · USPTO A61K / A61P
Patents matching “Theravance Biopharma R&D IP, LLC”
252 pharma patents match "Theravance Biopharma R&D IP, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 252 pharmaceutical patents matching "Theravance Biopharma R&D IP, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10836763
5 to 7 membered heterocyclic amides as JAK inhibitors
granted -
US 10829438
Neprilysin inhibitors
granted -
US 10774080
Pyrimidine compound as JAK kinase inhibitor
granted -
US 10759813
Neprilysin inhibitors
granted -
US 10752599
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
granted -
US 10745405
Glucuronide prodrugs of Janus kinase inhibitors
granted -
US 10744104
Neprilysin inhibitors
granted -
US 10745394
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
granted -
US 10722504
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
granted -
US 10696656
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
granted -
US 10577347
Crystalline forms of a biphenyl compound
granted -
US 10576073
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
granted -
US 10570120
Neprilysin inhibitors
granted -
US 10570092
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 10562894
Pyrimidine compound as JAK kinase inhibitor
granted -
US 10550081
Crystalline freebase forms of a biphenyl compound
granted -
US 10548879
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
granted -
US 10550118
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10548886
Methods of treatment using a JAK inhibitor compound
granted -
US 10538513
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
granted -
US 10526330
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 10519153
Fused imidazo-piperidine JAK inhibitors
granted -
US 10493077
Fused imidazo-piperidine JAK inhibitor compound
granted -
US 10494382
Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, methanol, N-N-dimethylformamide, and water
granted